cyanoprogesterone inhibits the corpus-luteum dehydrogenase with substantial selectivity. Because of its high affinity for the ovarian enzyme, the presence of lowmicromolar concentrations of 2a-cyanoprogesterone can promote a complete cessation of progesterone synthesis in corpora-lutea microsomes for several hours. Since this effect is observed in the presence of saturating concentrations of pregnenolone (50 M), it is predicted that this inhibitor may be even more potent in vivo. 2a-Cyanoprogesterone displays very low affinity for the human progesterone receptor, yielding a Kd of 600nM as against a Kd of 1.6nM for progesterone. It is suggested that 2a-cyanoprogesterone may be a selective inhibitor of ovarian progesterone synthesis and may act as an effective anti-gestational agent in vivo.
dione; 3,B-hydroxysteroid dehydrogenase, 3#-hydroxysteroid :NAD+ oxidoreductase (EC 1.1.1.51); R5020, promegestone, 17,21-dimethyl-19-norpregna-4,9-diene-3,20-dione; a-cyanoketone, 2a-cyano-4,4, 1 7-trimethyl- androst-5-en-1 7f-ol-3-one.
t To whom correspondence and requests for reprints should be sent. ment of an agent that could selectively inhibit either of these ovarian enzymes would decrease progesterone synthesis and could have therapeutic potential as a post-coital contraceptive or abortifacient. The development of such an agent has been unpopular, since these enzymes are also present in the adrenal cortex, where progesterone is the precursor of the mineralo-and glucocorticoids. Thus inhibition of mammalian progesterone synthesis is believed -to result in adverse effects on adrenal steroidogenesis. Such a belief rests on the assumption that both-the corpora-lutea and adrenal enzymes are equally sensitive to inhibition.
Goldman (1968) was the first to demonstrate that the a-cyanoketone was a tight-binding inhibitor of the bovine adrenal 3f,-hydroxysteroid de- hydrogenase (K, = 0.7Mm) and A5-3-oxosteroid isoVol. 230 merase (Ki = 0.6 gM). By using this compound in vivo, a marked inhibition of the adrenal-cortical, corpora-lutea and ovarian-follicular and stromalcell enzyme was observed (Goldman et al., 1965) . Furthermore, after a single injection of the synthetic steroid the inhibition was found to persist in vivo for a period of 4 weeks. This persistent inhibition resulted in adrenal and corpora-lutea hyperplasia, the former being reversed by the coadministration of glucocorticoids (Potts et al., 1963) . These findings suggest that selective inhibition of the ovarian dehydrogenase/isomerase system may be difficult to achieve.
Although the a-cyanoketone can inhibit ovarian and adrenal steroidogenesis, the potential of this compound and its [2,3-d] isoxazole, Win 17, 4, isoxazole) to act as anti-gestational agents in vivo has been assessed. Thus the [2,3-dlisoxazole can terminate pregnancy in both the pre-and postimplantation period in rats (Csapo & Resch, 1979a,b,c) . Similar findings have been observed in rhesus monkeys, where no changes in plasma glucocorticoid levels were observed (Schane et al., 1977) . It is thus conceivable that low-dose isoxazole may act as an effective anti-gestational agent in vivo.
As a further development in this area we have synthesized the a-cyanoketone of progesterone, namely 2a-cyanoprogesterone, and have shown it to be an active-site-directed affinity label for the crystalline A5-3-oxosteroid from Pseudomonas testosteroni (Penning, 1985) . The present paper describes the potent inhibition of mammalian progesterone synthesis by 2a-cyanoprogesterone and indicates that selective inhibition of ovarian progesterone synthesis is feasible.
Materials and methods Chemicals
[7-3H]Pregnenolone (19.3 Ci/mmol), [17a-methyl-3H]promegestone R5020, (80.0 Ci/mmol) and unlabelled R5020 were purchased from New England Nuclear (Boston, MA, U.S.A.). Pregnenolone, progesterone, 5a-dihydrotestosterone and dexamethasone were products of Steraloids (Wilton, NH, U.S.A.). 2a-Cyanoprogesterone, 2-hydroxymethylene progesterone, androst-5-ene-3,17-dione and pregn-5-ene-3,20-dione were synthesized as described previously (Penning, 1985 Spectrophotometric assay for A5-3-oxosteroid isomerases The standard spectrophotometric assay for mammalian A5-3-oxosteroid isomerases contained, in a final volume of 1.0ml, 100mM-potassium phosphate buffer, pH 7.0, 1.O,UM neutralized bovine serum albumin and 4% (v/v) acetonitrile containing either 68 kM-androst-5-ene-3,17-dione or 13.6gM-pregn-5-ene-3,20-dione. The reaction was initiated by the addition of resuspended microsomes, and the initial velocity of A4-3-oxosteroid formation (E= 16 300M-' cm-1; clmax 248 nm) was measured at 25°C against a blank containing all the components except steroid and enzyme. IC50 values (concentration causing 50% inhibition) for cyanoprogesterone and hydroxymethylene progesterone were obtained by adding increasing concentrations of the steroidal inhibitors to the assay system. The initial velocities were corrected for non-enzymic isomerization rates, which were less than 10% of the enzyme-catalysed velocity.
Human progesterone receptor assays
Portions of human breast tumour known to contain high levels of progesterone receptor were minced, pooled and homogenized in 5 vol. (w/v) of lOmM-Tris/HCl, pH7.4, containing 1 mM-EDTA, 1 mM-dithiothreitol, 10mM-sodium molybdate and 10% (v/v) glycerol. After centrifugation at 200 OOg the supernatants were pooled and aliquots were stored at -80°C for future use.
Progestin binding to the cytosolic receptor was assayed by using [3H]R5020 as ligand and dextrancoated charcoal to remove unbound steroid (de Hertogh et al., 1975) . Briefly, portions of the cytosol containing 0.35mg of protein/ml were incubated with various concentrations of [3H]R5020 (i.e. 0.lnM-3.0nM) at 4°C for 22h. To assess non-specific binding, duplicate tubes containing a 200-fold excess of unlabelled R5020 were included at the highest and lowest isotope concentrations. At the end of the incubation, dextrancoated charcoal was added to a final concentration of 0.25%, and after centrifugation at lOOOg a portion of the supernatant was counted for radioactivity to determine the amount of proteinbound radioligand. By subtracting this value from the total radioactivity the amount of free [3H]R5020 was determined. The pooled cytosol used in this study was found to contain 610+32fmol of progesterone receptor/mg of cytosol protein, with a Kd of 8.2 x 10-"1 (±1.2x10-1I)M and was stable throughout the course of the work. In competition experiments a similar binding isotherm was generated in the presence of a fixed concentration of competitor. In all the experiments the stock solutions of steroids were made in I100% ethanol, and the final concentration of organic solvent was kept constant at 0.5%.
After correcting bound radioactivity for nonspecific binding, double-reciprocal plots of bound R5020 versus the concentration of free R5020 were constructed. Data points were analysed by the Wilkinson (1961) 
Protein determinations
Protein concentrations were determined by the method of Lowry et al. (1951) , with crystalline bovine serum albumin as standard.
Results

Progesterone synthesis in mammalian endocrine tissues
The conversion of [3H]pregnenolone into progesterone was measured in microsomal resuspensions prepared from bovine corpora lutea, bovine adrenal cortex and human term placenta. In every instance the formation of progesterone was linear with respect to time (0-3 min) and protein concentration (result not shown). In general the reaction was complete within the first 5min of the assay.
Examination of the specific activities indicate that corpora-lutea microsomes are the most active, synthesizing 3 and 50 times more progesterone than either the adrenal or placental microsomes (Table 1) . By using androst-5-ene-3,17-dione and pregn-5-ene-3,20-dione to monitor the C,g-and C, l-A5-3-oxosteroid isomerase(s) in these preparations it is clear that the 3fB-hydroxysteroid dehydrogenase catalyses the rate-limiting step in the conversion of pregnenolone into progesterone.
Vol. 230 (Fig. 1) . 2a-Cyanoprogesterone was found to be an extraordinarily potent inhibitor of these reactions in bovine copora lutea, bovine adrenal cortex and human placental microsomes, yielding IC50 values of 66nM, 120nM and 700nM respectively. By contrast, the 2-hydroxymethylene progesterone was less potent, giving IC50 values that ranged from 1.4 to 35jiM. 2oa-Cyanoprogesterone is a selective inhibitor of the 3,B-hydroxysteroid dehydrogenase In theory, 2a-cyanoprogesterone could inhibit mammalian progesterone synthesis at one of two steps. First, it could prevent the oxidation of pregnenolone catalysed by the 3,B-hydroxysteroid dehydrogenase; alternatively it could inhibit the isomerization of the resulting pregn-5-ene-3,20-dione catalysed by the A5-3-oxosteroid isomerase. To identify the target enzyme we have examined whether 2a-cyanoprogesterone can prevent the isomerization of androst-5-ene-3, 1 7-dione and pregn-5-ene-3,20-dione. With either substrate the IC50 values generated were 400-1000 times higher than those observed for the conversion ofpregnenolone into progesterone (Table 2 ). Such data confirms that 2a-cyanoprogesterone acts as an extraordinarily potent and selective inhibitor of the 3,B-hydroxysteroid dehydrogenase.
By contrast, 2-hydroxymethyleneprogesterone inhibits the C21 -A5-3-oxosteroid isomerase at IC50 values comparable with those observed for its inhibition of the conversion of pregnenolone into progesterone ( Table 2 ). The possibility thus exists that 2-hydroxymethylene progesterone may exert all of its effect on the steroid isomerase.
2c-Cyanoprogesterone as a tight-binding competitive inhibitor of corpora-lutea 3/3-hydroxysteroid dehydrogenase Since 2a-cyanoprogesterone acts as an irreversible active-site-directed inhibitor of the bacterial oxosteroid isomerase (Penning, 1985) , the possibility existed that the tight binding to the mammalian 3,B-hydroxysteroid dehydrogenase was a reflection of covalent modification. To test this hypothesis, microsomes were preincubated with an excess of 2a-cyanoprogesterone, and samples were removed over a 2 h time period and diluted into the normal assay mixture. In such experiments no time-dependent inactivation of enzyme activity was observed. These data suggest that cyanoprogesterone acts as a reversible inhibitor of the dehydrogenase.
Dixon plots reveal that, in corpora-lutea microsomes, 2a-cyanoprogesterone acts as a potent competitive inhibitor of the 3,B-hydroxysteroid dehydrogenase, yielding a Ki value of 15 nm (Fig.   2 ). This value was obtained in two independent experiments and is substantially lower than the IC50 value (66nM) Since 2a-cyanoprogesterone is a reversible inhibitor of the 3,B-hydroxysteroid dehydrogenase, it is predicted that it will decrease the rate of progesterone formation and that it will take longer for the reaction to reach completion. It is also predicted that, in the presence or absence of inhibitor, the amount of progesterone eventually Table 1 . These velocities were then re-determined in the presence of the four to six concentrations of 2a-cyanoprogesterone indicated. In every instance velocities were measured in duplicate. In these assays the amount of radioactivity was kept constant at 40000 c.p.m. and the number of nmol of progesterone formed were calculated from the final specific radioactivity of [3H]pregnenolone used in the assay.
formed should be the same. Because 2a-cyanoprogesterone inhibits the dehydrogenase in the nanomolar range, we wished to determine whether micromolar concentrations of this inhibitor could prevent the reaction from ever reaching completion. In such experiments progesterone synthesis was monitored in corpus-luteum, adrenal-cortex and placenta microsomes over 2h in the presence of concentrations of 2a-cyanoprogesterone that exceed the IC50 values generated in Fig. 1 by as much as 80-fold. The results indicate that cyanoprogesterone was most effective in the corporalutea microsomes; thus O.SUM caused a significant decrease in progesterone synthesis, whereas 5.0,M promoted a complete cessation in the synthesis of this hormone over 2h (Fig. 3) [3H]R5020 was plotted by using a Lineweaver-Burk transformation. Kd and K, values were calculated as described in the Materials and methods section. synthesis in vivo. By contrast, the amount of 2a-cyanoprogesterone required to completely arrest progesterone synthesis in the adrenal cortex and human placenta would appear to exceed 20pM.
Progesterone-receptor assays
From the data, 2oc-cyanoprogesterone has the potential to act as an anti-gestational agent in vivo. Since this compound is an analogue of progesterone, it may also act as a progestin by binding to the cytoplasmic receptor. In competitive-binding assays, it was found that 4nM-progesterone could effectively displace [3H]R5020 from the human progestin receptor; however, similar displacement of the radioligand with cyanoprogesterone could only be achieved with concentrations that approached 4000nM (Fig. 4) . From these assays the Ki of progesterone was found to be 1.6nm and that for 2a-cyanoprogesterone was found to be 600nM. Such findings indicate that 2a-cyanoprogesterone displays very little affinity for the progestin receptor. The Ki value for 2a-cyanoprogesterone can be placed into further perspective when it is compared with similar values generated for 5a-dihydrotestosterone (K, 788 nM) and dexamethasone (Ki 840 nM). These findings suggest that cyanoprogesterone is no more a progestin than an active androgen or glucocorticoid.
Discussion
2a-Cyanoprogesterone is a potent reversible inhibitor of the rate-limiting step in the conversion of pregnenolone into progesterone catalysed by mammalian endocrine tissues. Thus it inhibits the 3,B-hydroxysteroid dehydrogenase in the nanomolar range, and it can cause complete cessation of progesterone synthesis for several hours in the lowmicromolar range. Its inhibitory effect is particularly powerful in the corpus luteum, where it acts as a competitive inhibitor, yielding an exceedingly low Ki of 15 nm. This Ki value is ten times lower than that observed for the 3fl-hydroxysteroid dehydrogenase of adrenal cortex and suggests that this compound may act as a selective inhibitor of ovarian progesterone synthesis. Since 2a-cyanoprogesterone has a very low affinity for the cytoplasmic progesterone receptor, this compound has the potential to act as an anti-gestational agent 'in vivo.
Although 2a-cyanoprogesterone resembles the cyanoketone studied by Goldman et al. (1965) and Goldman (1968) and the [2,3-d] isoxazole examined by Csapo & Resch (1979a,b,c) , it should be emphasized that this compound differs from these other two inhibitors in some important respects.
First, its Ki for the 3,B-hydroxysteroid dehydrogenase(s) indicates that its affinity exceeds that observed for the a-cyanoketone and [2,3-d]isoxazole by at least two orders of magnitude. Second, it displays extraordinarily high selectivity for the inhibition of the dehydrogenase; thus its potency for this enzyme is 400-1000-fold higher than that observed for the A5-3-oxosteroid isomerase (see Table 2 ). It should be recalled that the acyanoketone studied by Goldman (1968) displayed almost equal affinity for both the dehydrogenase and the isomerase of bovine adrenal cortex.
Further experiments are needed to determine whether 2a-cyanoprogesterone will traverse the cell membrane and inhibit progesterone synthesis in isolated corpora-lutea cells. If such experiments are successful, one will be able to progress to studies in vivo and evaluate the effectiveness of this compound as an anti-gestational agent. 
